Niagen Bioscience, Inc. (NAGE)
4.38
-0.14
(-3.10%)
USD |
NASDAQ |
Apr 02, 16:00
4.385
0.00 (0.00%)
After-Hours: 20:00
Niagen Bioscience Market Cap : 350.75M for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| SIGA Technologies, Inc. | 381.23M |
| Nephros, Inc. | 29.62M |
| Corcept Therapeutics, Inc. | 4.573B |
| Verastem, Inc. | 501.19M |
| Aldeyra Therapeutics, Inc. | 99.01M |
Market Cap Related Metrics
| PE Ratio | 21.44 |
| PS Ratio | 2.881 |
| PEG Ratio | 0.2285 |
| Price to Book Value | 4.583 |
| Price to Free Cash Flow | 28.37 |
| Price | 4.38 |
| Earnings Yield | 4.66% |
| PEGY Ratio | 0.2285 |
| Operating PE Ratio | 26.08 |
| Normalized PE Ratio | 21.42 |